Long-term subcutaneous treprostinil therapy evokes both survival benefits and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension

被引：0
|
作者：
Vachiery, JL [1 ]
Gautier, MT [1 ]
Huez, S [1 ]
Retailleau, K [1 ]
Naeije, R [1 ]
机构：
[1] Erasme Univ Hosp, Dept Cardiol, B-1070 Brussels, Belgium
来源：
CIRCULATION | 2003年 / 108卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1849
引用
收藏
页码：400 / 400
页数：1
相关论文
共 50 条
  • [1] Subcutaneous treprostinil therapy evokes both survival benefit and continuous dose-dependent efficacy improvements in patients with pulmonary arterial hypertension: A long-term European multicentre analysis of 112 patients
    Lang, I
    Gomez-Sanchez, M
    Kneussl, M
    Escribano, P
    Naeije, R
    Vachiery, JL
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 524A - 524A
  • [2] Long-term continuous subcutaneous treprostinil therapy for pulmonary arterial hypertension
    Skoro-Sajer, N
    Harja, E
    Bonderman, D
    Rezaie-Majd, S
    Machherndl, S
    Kneussl, M
    Lang, MI
    EUROPEAN HEART JOURNAL, 2003, 24 : 483 - 483
  • [3] Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension
    Lang, Irene
    Gomez-Sanchez, Miguel
    Kneussl, Meinhard
    Naeije, Robert
    Escribano, Pilar
    Skoro-Sajer, Nika
    Vachiery, Jean-Luc
    CHEST, 2006, 129 (06) : 1636 - 1643
  • [4] Long-term subcutaneous treprostinil (Remodulin) therapy for severe pulmonary arterial hypertension
    Skoro-Sajer, N.
    Bonderman, D.
    Harja, E.
    Jakowitsch, J.
    Maurer, G.
    Kneussl, M.
    Lang, I. M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 79 - 79
  • [5] Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil
    Barst, R. J.
    Galie, N.
    Naeije, R.
    Simonneau, G.
    Jeffs, R.
    Arneson, C.
    Rubin, L. J.
    EUROPEAN RESPIRATORY JOURNAL, 2006, 28 (06) : 1195 - 1203
  • [6] Tolerability and Efficacy of Subcutaneous Treprostinil Therapy in Patients with Pulmonary Arterial Hypertension
    Hatano, Masaru
    Maki, Hisataka
    Minatsuki, Shun
    Komuro, Issei
    JOURNAL OF CARDIAC FAILURE, 2016, 22 (09) : S193 - S193
  • [7] Long-term treatment of pulmonary arterial hypertension with treprostinil: Echocardiographic evaluation of efficacy
    Zwicke, D
    Lobacz, D
    Johnson, L
    Wade, M
    Roscigno, R
    CHEST, 2003, 124 (04) : 89S - 89S
  • [8] Combination Therapy For Pulmonary Arterial Hypertension With Oral Treprostinil: Long-Term Follow Up
    Ruggiero, R. M.
    Bartolome, S.
    Chin, K. M.
    Torres, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [9] USE OF SUBCUTANEOUS TREPROSTINIL IN PEDIATRIC PULMONARY ARTERIAL HYPERTENSION - BRIDGE-TO-TRANSPLANT OR LONG-TERM TREATMENT?
    Ablonczy, L.
    PEDIATRIC TRANSPLANTATION, 2017, 21 : 11 - 11
  • [10] Subcutaneous treprostinil therapy in pulmonary arterial hypertension due to congenital heart diseases - A long term multicentre analysis
    Vachiery, JL
    Pavelescu, A
    Lang, IM
    Skoro, N
    Gomez-Sanchez, MA
    Escribano, P
    Naeije, R
    CIRCULATION, 2005, 112 (17) : U480 - U481
12345